About GLATECT

GLATECT is a prescription medication containing the active ingredient Glatiramer Acetate, used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

Key Benefits & Uses

Treatment of relapsing forms of multiple sclerosis (MS)
Reduction of the frequency of clinical exacerbations
Delay of the progression of physical disability

Active Ingredient & Action

Glatiramer Acetate, the active ingredient in GLATECT, is a synthetic polypeptide that acts as an immunomodulator. It is believed to work by modifying the immune system's response to myelin, a fatty substance that surrounds and protects nerve fibers in the central nervous system. By reducing inflammation and preventing damage to the myelin sheath, Glatiramer Acetate helps to slow the progression of MS and reduce the frequency of clinical exacerbations.

Important Notes

GLATECT is available in a prefilled syringe for subcutaneous injection. It is essential to follow the recommended dosing schedule and administration instructions provided by your healthcare professional. Common side effects of GLATECT may include injection site reactions, flushing, and systemic immune activation. If you experience any unusual symptoms or have concerns about your treatment, consult your doctor or pharmacist for guidance.